Skip to main content
logo
Outlook Therapeutics logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.5000
+0.0298 (6.34%)
At close: Oct 15, 2026, 4:00 PM EDT
0.5099
+0.0099 (1.98%)
Pre-market: Oct 16, 2026, 4:47 AM EDT

Outlook Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-61.12-62.42-75.37-58.98-66.05-53.16
Depreciation & Amortization
0.10.120.110.040.20.26
Loss (Gain) on Equity Investments
0.170.140.10.010.050.05
Stock-Based Compensation
4.258.95.395.557.714.89
Other Operating Activities
5.15-4.973.995.653.10.79
Change in Accounts Receivable
0.11-1.49----
Change in Inventory
-0.92-3.34----
Change in Accounts Payable
-3.61.671.393.081.3-0.2
Change in Other Net Operating Assets
-0.299.58-4.411.67-2.98-6.88
Operating Cash Flow
-56.15-51.83-68.79-42.97-56.67-54.25
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Investment in Securities
-2.1-----
Investing Cash Flow
-2.1-----

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Long-Term Debt Issued
-33.1-301010
Long-Term Debt Repaid
--36.14-0-10.23-12.32-3.69
Net Debt Issued (Repaid)
-2.33-3.04-019.77-2.326.31
Issuance of Common Stock
65.3848.0360.3330.0262.5149.9
Other Financing Activities
-2.46---0.82-0.6-0.01
Financing Cash Flow
60.644.9860.3348.9759.5956.19

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Cash Flow
2.34-6.84-8.4662.921.94

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Free Cash Flow
-56.15-51.83-68.79-42.97-56.67-54.25
Free Cash Flow Growth
------
Free Cash Flow Margin
--3666.65%----
Free Cash Flow Per Share
-0.69-1.49-3.71-3.44-5.34-7.11
Levered Free Cash Flow
-37.36-27.15-44.3-24.26-32.53-35.62
Unlevered Free Cash Flow
-37.19-26.97-42.33-22.68-31.6-35.03

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash Interest Paid
--0.481.161.560.05
Change in Working Capital
-4.76.41-3.024.75-1.68-7.08
SEC Filings: 10-K · 10-Q